Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study identifies genetic risk factor for equine eye cancer
Squamous cell carcinoma (SCC) is the most common cancer of equine eyes.

Discovery will help to inform breeding decisions

Scientists at UD Davis School of Veterinary Medicine have identified the genetic risk factor for equine eye cancer.

Squamous cell carcinoma (SCC) is the most common cancer of equine eyes and the second most common cancer in horses.

Writing in the International Journal of Cancer, researchers announced the discovery of a genetic mutation in horses that is thought to impact the ability of DNA-binding protein 2 (DDB2) to repair UV-light damage.

“The mutation is predicted to alter the shape of the protein so it can't recognise UV-damaged DNA,” said equine geneticist Dr Rebecca Bellone. “We believe this is a risk factor because cells can’t repair the damage and accumulate mutations in the DNA that lead to cancer.”

Ocular SCC can cause blindness and even the loss of the eye. In advanced cases, it can spread to the orbit, eat away at the bone - and eventually the brain - leading to loss of life. The results of this study will be able to inform owners in two ways, as research partner Dr Mary Lassaline explains:

“One, it’s important for the individual horse with a known risk and we can be more vigilant about exams as well as protecting their eyes from UV exposure.  If detected early, we can remove the tumour and save the eye. Secondly, that knowledge is important for making informed breeding decisions.”

Based on the research, scientists at UC Davis Genetics Laboratory were able to develop a genetic test. The test shows if a horse carries the mutation or has two copies of the risk variant, putting it at high risk of cancer.

It is also hoped the research will have implications for human health, as the gene found to be associated with equine SCC is also linked in humans to a skin cancer known as Xeroderma Pigmentosum group E. 

Image (C) UC Davis School of Veterinary Medicine

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.